Nephros claims US first for haemodiafiltration
This article was originally published in Clinica
Executive Summary
Signalling the company's entry into the US renal care market, New York-based Nephros has received FDA 510(k) clearance to market its OLpur HD190 high flux filter for use in treatments for kidney failure.